Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Cash Flow (2016 - 2021)

Historic Net Cash Flow for Neurocrine Biosciences (NBIX) over the last 12 years, with Q4 2021 value amounting to $29.7 million.

  • Neurocrine Biosciences' Net Cash Flow rose 11246.85% to $29.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $153.7 million, marking a year-over-year increase of 10548.13%. This contributed to the annual value of -$18.1 million for FY2024, which is 5210.08% down from last year.
  • Neurocrine Biosciences' Net Cash Flow amounted to $29.7 million in Q4 2021, which was up 11246.85% from -$56.9 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Net Cash Flow registered a high of $244.9 million during Q2 2017, and its lowest value of -$238.2 million during Q4 2020.
  • In the last 5 years, Neurocrine Biosciences' Net Cash Flow had a median value of $1.1 million in 2018 and averaged $12.8 million.
  • In the last 5 years, Neurocrine Biosciences' Net Cash Flow soared by 96198.18% in 2019 and then tumbled by 65784.31% in 2021.
  • Over the past 5 years, Neurocrine Biosciences' Net Cash Flow (Quarter) stood at -$13.2 million in 2017, then plummeted by 308.5% to -$54.0 million in 2018, then decreased by 4.26% to -$56.3 million in 2019, then tumbled by 323.09% to -$238.2 million in 2020, then soared by 112.47% to $29.7 million in 2021.
  • Its Net Cash Flow stands at $29.7 million for Q4 2021, versus -$56.9 million for Q3 2021 and $15.4 million for Q2 2021.